Identifying The Optimal Age To Apply Physical Activity Interventions To Improve Heart Health
Funder
National Health and Medical Research Council
Funding Amount
$852,804.00
Summary
By performing sophisticated, novel and sensitive measurements on the heart at age 30 and linking these to richly characterised historical data, we will determine whether there is an optimal age to apply physical activity interventions to improve adult heart health. This is possible using data collected from 18 weeks pregnancy through to adulthood in ~3,000 Australians. This study will inform policy and interventions to reduce heart disease; the single biggest cause of mortality in Australia.
DImensional Attention MOdelling For Neglect Detection (DIAMOND): A Novel Application For Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$513,483.00
Summary
One in three people experience neglect disorder after brain injury, where half of their visual world appears missing. Neglect is a persistent and distressing cognitive problem impacting all aspects of daily life, and is typically under-diagnosed and poorly treated. We have built a novel 3D technology platform for precision detection of neglect, and for informing personalised treatment options. This systematic feasibility project will establish early evidence for advanced neglect assessment.
Imaging, Fluid And Genetic Markers Of Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$1,519,004.00
Summary
Markers of pathology and inflammation are useful tools for the diagnosis and staging of neurodegenerative conditions such as Alzheimer's disease. This approach will deepen our basic understanding of this disease, improving early detection and prediction of cognitive impairment. This work will make possible more accurate diagnosis, and improved monitoring of therapeutic interventions.
A Novel Interaction Between The Immune And Vascular Systems In Early-onset Preeclampsia; An Opportunity For New Treatments?
Funder
National Health and Medical Research Council
Funding Amount
$921,623.00
Summary
Preeclampsia is a pregnancy complication that leads to poor birth outcomes and elevated lifelong cardiovascular disease risk in 4 million women each year. It has no cure and treatments are limited because the causal mechanisms are not understood. We have identified a specialised immune cell in the mother's blood that assists blood vessels to function properly in pregnancy. We will assess whether interventions to enhance these cells can improve poor blood vessel function and pregnancy outcomes.
Developing An In Vitro Model Of A Human Blastocyst
Funder
National Health and Medical Research Council
Funding Amount
$890,062.00
Summary
Using novel cellular and molecular technologies we propose to develop an artificial model of an early human blastocyst. This will allow us to study the first initial steps in human development without the use of real embryos. Such a model will not only help us decipher the first steps in human development, but we anticipate it will be essential to study how gene mutations and the environment affect this initial step in human development.
Vaccine To Prevent Influenza Virus And Bacterial Super-infection.
Funder
National Health and Medical Research Council
Funding Amount
$707,717.00
Summary
Influenza viruses have the ability to pre-dispose infected hosts toward secondary bacterial complications. The mortality of viral infections that are complicated by a concurrent, or subsequent, bacterial infection (known as a super-infection), is often greater than that of either the virus or the bacteria alone. We will develop a novel multi-pathogen vaccine candidate against the major upper respiratory tract pathogens - Influenza A and Streptococcus pyogenes to prevent super-infections.
Growth Factor Directed Developmental And Pathological Lymphangiogenesis
Funder
National Health and Medical Research Council
Funding Amount
$1,048,507.00
Summary
The formation of new lymphatic vessels occurs in normal development and in diseased tissues in cancer and cardiovascular disease. We have developed an understanding of how lymphatics form in development but we understand far less about how they form in disease. This project will apply multidisciplinary approaches, including genetics and computational biology, to compare how lymphatics form in development and disease. We hope to uncover new ways to manipulate this process for therapeutic gain.
Relaxin Receptor Structural Determination To Aid Therapeutic Development
Funder
National Health and Medical Research Council
Funding Amount
$1,249,114.00
Summary
The receptor for the peptide hormone relaxin, RXFP1, is being targeted by numerous drug companies for the treatment of cardiovascular disease. However, the lack of molecular detail of how relaxin binds and activates RXFP1 is hindering new drug development. We will determine the structure of the complex of relaxin bound to RXFP1 and the mechanism by which this activates cells. The knowledge gained will aid in the design of new drugs targeting RXFP1 for the treatment of cardiovascular disease.
Harnessing The Benefits Of Autonomous Vehicles For Health
Funder
National Health and Medical Research Council
Funding Amount
$738,596.00
Summary
The arrival of autonomous vehicles (AVs) will have huge implications for health behaviours, including physical activity and diet. It is critical that appropriate planning processes are undertaken as early as possible to prevent cities of the future being designed around AVs rather than people, thereby losing the potential for this new technology to be harnessed as a means of enhancing health. This project will facilitate the inclusion of health considerations in AV implementation processes.
Reprogramming Human Fibroblasts Into Induced Trophoblast Stem Cells
Funder
National Health and Medical Research Council
Funding Amount
$889,064.00
Summary
We have been able to generate artificial human trophectoderm which is the tissue that creates the placenta. This will allow us to do research in how the genes control the fate of these cells without the need of human embryos or placenta. We anticipate that the derivation and characterising these cells will revolutionise placenta research, which in turn will contribute to the establishment of new therapies for placenta disease and infertility.